165 related articles for article (PubMed ID: 26873546)
1. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.
Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG
Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546
[TBL] [Abstract][Full Text] [Related]
2. Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F
Desai VG; Lee T; Moland CL; Vijay V; Han T; Lewis SM; Herman EH; Fuscoe JC
Toxicol Appl Pharmacol; 2019 Jan; 363():164-173. PubMed ID: 30517846
[TBL] [Abstract][Full Text] [Related]
3. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411
[TBL] [Abstract][Full Text] [Related]
4. Early biomarkers of doxorubicin-induced heart injury in a mouse model.
Desai VG; C Kwekel J; Vijay V; Moland CL; Herman EH; Lee T; Han T; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC
Toxicol Appl Pharmacol; 2014 Dec; 281(2):221-9. PubMed ID: 25448438
[TBL] [Abstract][Full Text] [Related]
5. Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model.
Desai VG; Herman EH; Moland CL; Branham WS; Lewis SM; Davis KJ; George NI; Lee T; Kerr S; Fuscoe JC
Toxicol Appl Pharmacol; 2013 Jan; 266(1):109-21. PubMed ID: 23142469
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
[TBL] [Abstract][Full Text] [Related]
8. Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats.
Thompson KL; Rosenzweig BA; Zhang J; Knapton AD; Honchel R; Lipshultz SE; Retief J; Sistare FD; Herman EH
Cancer Chemother Pharmacol; 2010 Jul; 66(2):303-14. PubMed ID: 19915844
[TBL] [Abstract][Full Text] [Related]
9. Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.
Schnackenberg LK; Pence L; Vijay V; Moland CL; George N; Cao Z; Yu LR; Fuscoe JC; Beger RD; Desai VG
J Appl Toxicol; 2016 Nov; 36(11):1486-95. PubMed ID: 26934058
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
[TBL] [Abstract][Full Text] [Related]
11. Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats.
Gonzalez Y; Pokrzywinski KL; Rosen ET; Mog S; Aryal B; Chehab LM; Vijay V; Moland CL; Desai VG; Dickey JS; Rao VA
Cancer Chemother Pharmacol; 2015 Sep; 76(3):447-59. PubMed ID: 26108538
[TBL] [Abstract][Full Text] [Related]
12. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
Zhang S; Meng T; Liu J; Zhang X; Zhang J
Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
Rocha VC; França LS; de Araújo CF; Ng AM; de Andrade CM; Andrade AC; Santos Ede S; Borges-Silva Mda C; Macambira SG; Noronha-Dutra AA; Pontes-de-Carvalho LC
Cancer Chemother Pharmacol; 2016 Mar; 77(3):659-62. PubMed ID: 26712129
[TBL] [Abstract][Full Text] [Related]
14. Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F
Jenkins GR; Lee T; Moland CL; Vijay V; Herman EH; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC; Desai VG
Toxicol Appl Pharmacol; 2016 Nov; 310():159-174. PubMed ID: 27644598
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity.
Desai VG; Vijay V; Lee T; Han T; Moland CL; Phanavanh B; Herman EH; Stine K; Fuscoe JC
J Appl Toxicol; 2022 Sep; 42(9):1477-1490. PubMed ID: 35199358
[TBL] [Abstract][Full Text] [Related]
16. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.
Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB
Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580
[TBL] [Abstract][Full Text] [Related]
17. Preclinical models of cardiac protection and testing for effects of dexrazoxane on doxorubicin antitumor effects.
Imondi AR
Semin Oncol; 1998 Aug; 25(4 Suppl 10):22-30. PubMed ID: 9768820
[TBL] [Abstract][Full Text] [Related]
18. Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
Saadane N; Yue P; Alpert L; Mitmaker B; Kirby GM; Chalifour LE
Can J Physiol Pharmacol; 2001 Jun; 79(6):533-44. PubMed ID: 11430591
[TBL] [Abstract][Full Text] [Related]
19. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
[TBL] [Abstract][Full Text] [Related]
20. Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane.
Della Torre P; Mazué G; Podestà A; Moneta D; Sammartini U; Imondi AR
Cancer Chemother Pharmacol; 1999; 43(2):151-6. PubMed ID: 9923821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
